alpha-methylhistamine has been researched along with Hyperplasia in 1 studies
alpha-methylhistamine: a histamine H3 receptor agonist; RN given refers to parent cpd without isomeric designation
alpha-methylhistamine : An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, H | 1 |
| Franchitto, A | 1 |
| Ueno, Y | 1 |
| Glaser, S | 1 |
| DeMorrow, S | 1 |
| Venter, J | 1 |
| Gaudio, E | 1 |
| Alvaro, D | 1 |
| Fava, G | 1 |
| Marzioni, M | 1 |
| Vaculin, B | 1 |
| Alpini, G | 1 |
1 other study available for alpha-methylhistamine and Hyperplasia
| Article | Year |
|---|---|
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.
Topics: Animals; Bile Ducts; Bile Ducts, Intrahepatic; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent | 2007 |